BioSpace News Archive

The global ENT medical devices market is projected to record a steady growth at a CAGR of 5.5% during the forecast period from 2021 to 2031, as per a study by Fact.MR

Rising prevalence of scar contractures and increasing demand for non-invasive procedure aesthetic surgeries are expected to bolster the growth of the market

Fact MR: The global lab automation market is forecast to surpass the valuation of US$ 1 trillion by end of 2031.

According to the report, the global atipamezole market was valued at US$ 60 Mn in 2019. It is projected to expand at a CAGR of ~1% from 2020 to 2030.

Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles.

Seventy percent of employers have been negatively impacted by the coronavirus pandemic and more than half have implemented cost-cutting measures that affected their employees, according to Navigating the Pandemic: A Survey of U.S. Employers, a report released by nonprofit Transamerica Institute® and its Transamerica Center for Retirement Studies®.

ImaBiotech Group announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites.

ONK Therapeutics Ltd, an innovative natural killer cell therapy company, announced that it has been awarded an Innovation Partnership Programme grant by Enterprise Ireland to fund collaborative research at Trinity College Dublin, Ireland, led by Dr. David Finlay to optimize the metabolism and engineering of NK cells for improved cancer therapies.

Testing people for SARS-CoV-2 has just been made easier and more accessible with United States Food and Drug Administration emergency use authorization of the combination of SalivaDirect™ with Ubiquitome’s Liberty16 mobile real time-PCR.

Amsterdam, the Netherlands – Royal Philips announced that the exchange ratio for the dividend in shares for the year 2020 has been determined.